Hunter Perkins Capital Management’s Mersana Therapeutics MRSN Stock Holding History

Hunter Perkins Capital Management’s Portfolio MRSN Stock Details MRSN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-400	Closed	-$3K	–	116
2025 Q2	$3K	Hold	400	–	–	﹤0.01%	110
2025 Q1	$3K	Hold	400	–	–	﹤0.01%	104
2024 Q4	$14K	Hold	400	–	–	﹤0.01%	104
2024 Q3	$19K	Hold	400	–	–	﹤0.01%	106
2024 Q2	$20K	Sell	400 -200	-33%	-$14.5K	﹤0.01%	107
2024 Q1	$67K	Sell	600 -428	-42%	-$42.5K	0.01%	105
2023 Q4	$60K	Sell	1,028 -452	-31%	-$18.2K	0.01%	87
2023 Q3	$47K	Buy	+1,480	New	+$70.3K	0.01%	124

Other funds holding MRSN

Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

Alamea Verwaltungs Edison, New Jersey $135M AUM 36.32% 1-Year Est. Return

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Schonfeld Strategic Advisors New York $12.3B AUM 37.17% 1-Year Est. Return

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Acadian Asset Management

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Silverarc Capital Management Boston, Massachusetts $849M AUM 470.8% 1-Year Est. Return

683 Capital Management New York $1.08B AUM 85.52% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return